Recursion raises $121m for AI-led drug discovery

Retrieved on: 2019-07-15 16:48:45

Tags for this article:

Health

Artificial intelligence

Pharmaceutical industry

Drug discovery

Insilico Medicine

Celgene

Biotechnology companies

Sutro Biopharma

BenevolentAI

Pharmaceutical sciences

Drug repositioning

Drug pipeline

Click the tags to see associated articles and topics

Recursion raises $121m for AI-led drug discovery. View article details on hiswai:

Excerpt

<div>Numerous other companies are pioneering AI-led drug discovery, including Berg, BenevolentAI, <b>Insilico Medicine</b> and Exscientia. In March, Celgene ...</div>

Article found on:

View Original Article